PMAH:OTCPLASMATECH INC Analysis

RSI is at the maximum of 100 while the technicals show a bearish trend with the 20‑, 50‑ and 200‑day SMAs all converging at the current price of $0.00001. Volume is stable but extremely low, with a market cap of only $709 and daily volume around 5,000 shares, indicating severe liquidity constraints. The company carries $128,000 of debt against zero cash and a negative book value per share of -$0.002, resulting in a negative price‑to‑book ratio and no meaningful earnings or cash flow generation. Operating performance is dire, with a gross margin of 100% that is meaningless given a operating margin of -24.98% and an operating cash outflow of -$63,657. The price‑to‑sales multiple of 0.2836 masks the fact that revenue is stagnant at $2,500 and growth is flat, offering no upside catalyst.
Given the combination of zero volatility, a beta reported as 0 (contrasted with an implausibly high quote beta), and a lack of analyst coverage, the stock sits in a high‑risk niche of development‑stage technology firms. The fear‑greed index reading of 72.88 (“Greed”) reflects market optimism that is not supported by fundamentals, and the absence of dividends or sustainable cash generation further erodes confidence. In short, the quantitative picture is one of extreme financial distress, negligible liquidity, and technical indicators that suggest continued downside pressure.